Stay updated on CT: ctDNA-Enriched Post-neoadjuvant Trial for Triple Negative Breast Cancer
Sign up to get notified when there's something new on the CT: ctDNA-Enriched Post-neoadjuvant Trial for Triple Negative Breast Cancer page.

Latest updates to the CT: ctDNA-Enriched Post-neoadjuvant Trial for Triple Negative Breast Cancer page
- Check7 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check14 days agoChange DetectedA notice announces NIH website changes and says federal agencies are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.5%

- Check21 days agoChange DetectedThe footer’s site revision label advances from v3.7.1 to v3.7.2; the study record history remains unchanged.SummaryDifference0.1%

- Check28 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check49 days agoChange DetectedThe study record history now includes a new revision entry v3.7.0 and removes the previous revision v3.6.6. This update reflects an updated metadata entry for the record.SummaryDifference0.1%

- Check70 days agoChange DetectedRecord History now shows the latest site revision as v3.6.6, replacing the previous v3.6.5; this reflects a small platform update in the page footer.SummaryDifference0.1%

Stay in the know with updates to CT: ctDNA-Enriched Post-neoadjuvant Trial for Triple Negative Breast Cancer
Enter your email address, and we'll notify you when there's something new on the CT: ctDNA-Enriched Post-neoadjuvant Trial for Triple Negative Breast Cancer page.